ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial
Trial details
- Registry ID
- NCT06828861
- Drugs studied
- ARD-101
TrialRedline tracks 6 clinical trials sponsored by Aardvark Therapeutics, Inc.: 2 Phase 3, 4 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialNCT06828861 | ARD-101 | Terminated | 2026-05-07Actual |
| The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialNCT07197034 | ARD-101 | Terminated | 2026-04-15Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Evaluate ARD-501 in Patients With Autism Spectrum DisorderNCT06126653 | High Dose ARD-501, Low Dose ARD-501 | Completed | 2025-01-13Actual |
| A Study of Oral ARD-101 in Patients With Prader-Willi SyndromeNCT05153434 | ARD-101 | Completed | 2024-09-24Actual |
| Study to Evaluate ARD-101 in Adults Receiving Bariatric SurgeryNCT05215847 | ARD-101 | Completed | 2023-02-03Actual |
| Study to Evaluate ARD-101 in Adults With ObesityNCT05121441 | ARD-101 | Completed | 2022-11-09Actual |
Names as written in the registry records.
NCT05153434 · Aardvark Therapeutics, Inc.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Incidence of Treatment-Emergent Adverse Events (TEAE). After: Measure: Incidence of Treatment Emergent Adverse Events (TEAE).
NCT07197034 · Aardvark Therapeutics, Inc.
Before: Estimated. After: Actual.
Before: 90 participants (planned). After: 19 participants (actual).
Before: Estimated. After: Actual.
Before: Mar 2027. After: 15 Apr 2026.
Before: Suspended. After: Terminated.
NCT06828861 · Aardvark Therapeutics, Inc.
Before: Estimated. After: Actual.
Before: 90 participants (planned). After: 68 participants (actual).
Before: Estimated. After: Actual.
Before: Mar 2027. After: 7 May 2026.
Before: Suspended. After: Terminated.
NCT06828861 · Aardvark Therapeutics, Inc.
Before: Mar 2026. After: Mar 2027.
NCT07197034 · Aardvark Therapeutics, Inc.
Before: Recruiting. After: Suspended.
NCT06828861 · Aardvark Therapeutics, Inc.
Before: Recruiting. After: Suspended.